Literature DB >> 9222380

Neurocytotoxity of quinolinic acid in human brain cultures.

S J Kerr1, P J Armati, B J Brew.   

Abstract

Quinolinic acid (QUIN) is a tryptophan metabolite which has been found to be an excitotoxin in rats, although its toxicity in humans is unknown. QUIN has been implicated in the pathogenesis of AIDS dementia complex. This study examined the effect of QUIN on human fetal brain tissue in vitro. After at least 14 days in vitro, QUIN was added to the cultures in the feeding medium, and lactate dehydrogenase (LDH) efflux at 20 h and neuronal morphology were used as a measure of neuronal injury. LDH levels in media from cultures exposed to QUIN concentrations of 5 and 10 mM were consistently elevated compared to controls. Overall, LDH levels in media from cultures exposed to lower QUIN concentrations did not differ significantly from controls. These data are comparable to animal in vitro studies, and support the hypothesis that QUIN is toxic to human central nervous system neurons and further strengthen its potential role in the pathogenesis of AIDS dementia complex.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9222380     DOI: 10.3109/13550289509111027

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  12 in total

1.  Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat.

Authors:  D G Smith; G J Guillemin; L Pemberton; S Kerr; A Nath; G A Smythe; B J Brew
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

Review 2.  Involvement of quinolinic acid in AIDS dementia complex.

Authors:  Gilles J Guillemin; Stephen J Kerr; Bruce J Brew
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 3.  The signaling and apoptotic effects of TNF-related apoptosis-inducing ligand in HIV-1 associated dementia.

Authors:  Y Huang; N Erdmann; J Zhao; J Zheng
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

Review 4.  The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications.

Authors:  Judit Füvesi; Cecilia Rajda; Krisztina Bencsik; József Toldi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2012-01-19       Impact factor: 3.575

Review 5.  Tryptophan, adenosine, neurodegeneration and neuroprotection.

Authors:  T W Stone; C M Forrest; G M Mackay; N Stoy; L G Darlington
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

6.  Changes in Cathepsin D and Beclin-1 mRNA and protein expression by the excitotoxin quinolinic acid in human astrocytes and neurons.

Authors:  Nady Braidy; Bruce J Brew; Nibaldo C Inestrosa; Roger Chung; Perminder Sachdev; Gilles J Guillemin
Journal:  Metab Brain Dis       Date:  2014-05-16       Impact factor: 3.584

7.  Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons.

Authors:  Nady Braidy; Ross Grant; Seray Adams; Bruce J Brew; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2009-04-18       Impact factor: 3.911

8.  Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder.

Authors:  Nicholas W S Davies; Gilles Guillemin; Bruce J Brew
Journal:  Int J Tryptophan Res       Date:  2010-06-10

9.  Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease.

Authors:  Ka Ka Ting; Bruce J Brew; Gilles J Guillemin
Journal:  J Neuroinflammation       Date:  2009-12-10       Impact factor: 8.322

10.  The excitotoxin quinolinic acid induces tau phosphorylation in human neurons.

Authors:  Abdur Rahman; Kaka Ting; Karen M Cullen; Nady Braidy; Bruce J Brew; Gilles J Guillemin
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.